Compare Gemini Space Station Inc (GEMI) vs IDEXX Laboratories, Inc. (IDXX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Gemini Space Station Inc vs IDEXX Laboratories, Inc. — how do they compare? Gemini Space Station Inc trades at $4.18 (market cap $512.05M), while IDEXX Laboratories, Inc. trades at $569.65 (market cap $46.22B). The key difference: IDEXX Laboratories, Inc. is far larger — about 90.3× Gemini Space Station Inc's market cap, and IDEXX Laboratories, Inc. is trading nearer its 52-week high, Gemini Space Station Inc nearer its low. Which is the better fit depends on your goals.
| GEMI | IDXX | |
|---|---|---|
Market Cap | $512.05M | $46.22B |
Sector | Technology | Health |
52-Week High | $32.52 | $766.68 |
52-Week Low | $3.90 | $526.44 |
Enterprise Value | $502.04M | $47.12B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Gemini Space Station (GEMI) trades at $4.085, down 0.61% on the day, with technical indicators showing a bearish trend. The company reported significant losses with a net income margin of -278.9% in 2025 and has missed earnings expectations for three consecutive quarters. Recent developments include a $100 million investment from Winklevoss Capital and the launch of commission-free stock trading as part of its super app strategy.
Despite analyst consensus pointing to upside potential with a $6.33 price target, GEMI faces substantial execution risks amid ongoing securities lawsuits and persistent negative profitability. The stock presents high-risk speculative appeal for investors betting on the company's financial infrastructure transformation, but current fundamentals remain deeply concerning.
IDEXX Laboratories (IDXX) trades at $570.58, down 4.23% over 24 hours, with a bullish technical signal and strong fundamentals. The stock has consistently beaten earnings estimates, with Q2 2026 EPS of $4.27 surpassing the $3.94 expectation. Revenue growth remains robust, supported by a 74.21% ROE and expanding diagnostic offerings. Recent news highlights product expansion, including a dual-species cardiac test, reinforcing its market leadership in veterinary diagnostics.
The outlook is positive, driven by durable competitive advantages and international growth potential. However, elevated valuation multiples and competitive pressures pose risks. Analyst consensus is bullish with a $683.33 price target, suggesting significant upside from current levels, though investors should monitor execution on guidance and macroeconomic headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Gemini Space Station Inc
Gemini Space Station Inc is the parent company of the Gemini crypto ecosystem, founded by Cameron and Tyler Winklevoss. It operates as a regulated digital asset exchange and custodian, providing a platform for individuals and institutions to trade, store, and stake cryptocurrencies while serving as a trusted bridge between legacy finance and the decentralized web.
Read more on GEMI →About IDEXX Laboratories, Inc.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets about 38% of its revenue from outside the United States.
Read more on IDXX →
